Fosun Pharma's Hong Kong IPO Set to Raise $600 Million

Published: Oct 05, 2012

by Richard Daverman, PhD

October 5, 2012 -- Fosun Pharma’s long-in-the-works IPO on the Hong Kong exchange is scheduled to take place this month, raising a diminished $600 million. The company received regulatory approval for the offering five months ago, but market conditions have held the transaction back until now – and caused the company to drop the projected take from $800 million. There have been no IPOs in Hong Kong for the last three months. More details....

Stock Symbol: (SHA: 600196)

Back to news